© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 21, 1630-1635,
November 1, 1995
© 1995 Oxford University Press
Increased N-Myristoyltransferase Activity Observed in Rat and Human Colonic Tumors
Department of Pathology and Saskatoon Cancer Centre, College of Medicine, University of Saskatchewan Saskatoon, SK, Canada
Correspondence to: R. K. Sharma, Ph.D., Department of Pathology and Saskatoon Cancer Centre, College of Medicine, University of Saskatchewan. Saskatoon. SK S7N 4H4, Canada.
Background: Colorectal cancer is one of the leading causes of cancer death in North America. Since treatment of colonic cancer remains difficult because of the lack of effective chemotherapeutic agents, it is important to continue to search for cellular functions that can be disrupted by chemotherapeutic drugs and inhibit the development or progression of this disease. Modification of proteins by myristoylation has been recognized as important in the function of various viral, oncogenic, and signal-transduction proteins and thus has been proposed as a target for chemotherapeutic drug design. However, the activity of the enzyme that catalyzes this modification, N-myristoyltransferase, has not been investigated in cancer relative to normal tissue. Purpose: The Purpose of this study was twofold: 1) to investigate the activity of N-myristoyltransferase in azoxymethane-induced rat colonic cancer tissue compared with normal and normal-appearing rat colonic tissue and 2) to determine if similar differences would be observed in a small sample of human colonic tumors. Methods: N-Myristoyltransferase activity was determined in 45 colonic tissue specimens from Sprague-Dawley rats—10 given injections of the colon carcinogen, azoxymethane, and three untreated. Tissue specimens included 35 colonic tumors of varying pathologic stages, seven specimens of normal-appearing adjacent mucosa, and three specimens of normal colonic mucosa. Colectomy specimens from five patients were assayed for N-my-ristoyltransferase activity. Subcellular distribution of N-myristoyltransferase activity was determined. Synthetic peptides of known myristoylated proteins—pp60src and cyclic adenosine monophosphate-dependent protein kinase—were used in kinetic analyses of N-myristoyltransferase in colonic cancer and normal-appearing colonic tissue. All P values are two-tailed. Results: N-Myristoyltransferase activity was increased in rat colonictumors compared with normal-appearing adjacent mucosa and normal mucosa (P = .0002). Elevation of N-myristoyltransferase activity was present in all tumors, including colonic polyps. Increased N-myristoyltransferase activity was also observed in human colonic tumors and was predominantly cytosolic. N-Myristoyltransferase of colonic cancer tissues had a similar Michaelis constant but an approximate twofold higher maximum velocity for both the pp60src- and cyclic adenosine monophosphate-dependent protein kinase-derived peptides compared with N-myristoyltransferase of normal-appearing tissue. Conclusions: This study demonstrates for the first time that N-myristoyltransferase activity is higher in colonic epithelial neoplasms than in normal-appearing colonic tissue and that an increase in N-myristoyltransferase activity appears at an early stage in colonic carcinogenesis. [J Natl Cancer Inst 1995;87:1630–5]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Shrivastav, S. Varma, Z. Lawman, S. H. Yang, S. A. Ritchie, K. Bonham, S. M. Singh, A. Saxena, and R. K. Sharma Requirement of N-Myristoyltransferase 1 in the Development of Monocytic Lineage J. Immunol., January 15, 2008; 180(2): 1019 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Ducker, J. J. Upson, K. J. French, and C. D. Smith Two N-Myristoyltransferase Isozymes Play Unique Roles in Protein Myristoylation, Proliferation, and Apoptosis Mol. Cancer Res., August 1, 2005; 3(8): 463 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shrivastav, M. K. Pasha, P. Selvakumar, B. Singh, and R. K. Sharma Expression, Localization, and Correlation of N-Myristoyltransferase and Its Inhibitor in Bovine Eye Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1674 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Selvakumar, A. Lakshmikuttyamma, R. Kanthan, S. C. Kanthan, J. R. Dimmock, and R. K. Sharma High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas Clin. Cancer Res., April 15, 2004; 10(8): 2771 - 2775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shrivastav, M. K. Pasha, P. Selvakumar, S. Gowda, D. J. H. Olson, A. R. S. Ross, J. R. Dimmock, and R. K. Sharma Potent Inhibitor of N-Myristoylation: A Novel Molecular Target For Cancer Cancer Res., November 15, 2003; 63(22): 7975 - 7978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Kolluri, C. Balduf, M. Hofmann, and M. Gottlicher Novel Target Genes of the Ah (Dioxin) Receptor: Transcriptional Induction of N-Myristoyltransferase 2 Cancer Res., December 1, 2001; 61(23): 8534 - 8539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Giang and B. F. Cravatt A Second Mammalian N-Myristoyltransferase J. Biol. Chem., March 20, 1998; 273(12): 6595 - 6598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Glover, K. D. Hartman, and R. L. Felsted Human N-Myristoyltransferase Amino-terminal Domain Involved in Targeting the Enzyme to the Ribosomal Subcellular Fraction J. Biol. Chem., November 7, 1997; 272(45): 28680 - 28689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, E. Jackson-Machelski, and J. I. Gordon Biochemical Studies of Saccharomyces cerevisiae Myristoyl-coenzyme A:Protein N-Myristoyltransferase Mutants J. Biol. Chem., December 20, 1996; 271(51): 33131 - 33140. [Abstract] [Full Text] [PDF]
|
|